"The EDSS has a number of limitations and may also measure changes that are not related to MS, such as older age and multiple ...

A multiple sclerosis patient shares essential guidance from her 13-year diagnostic journey, offering hope and practical tips ...

Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in ...

Most MS treatments don't increase the risk for miscarriage or major birth defects when used during pregnancy, an analysis ...

Oct. 17, 2024 — In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in ... New Study Finds a ...

Oct. 17, 2024 — In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in ... New Study Finds a ...

The most-read stories published by Multiple Sclerosis News Today in 2024 focused on living with MS and news on disease risk factors.

ANK-700 is under clinical development by Anokion and currently in Phase I for Relapsing Remitting Multiple Sclerosis (RRMS).

Many people living with the degenerative neurological disease multiple sclerosis (MS) are premenopausal women. This means ...